Intriguingly, the RUNX1 mutation was observed at an approx. VAF of 50%, despite the obvious phenotypical heterogeneity with typical BPDCN, infiltrates alongside cells more typical of pDC-like AML emerging from an MDS, suggesting a partially shared clonal architecture. This evidence concerns the gene RUNX1 and acute myeloid leukemia.